CHARLES FOULDS to Antineoplastic Agents, Hormonal
This is a "connection" page, showing publications CHARLES FOULDS has written about Antineoplastic Agents, Hormonal.
Connection Strength
0.302
-
Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer. Cancer Res. 2021 12 15; 81(24):6259-6272.
Score: 0.168
-
Disrupting a negative feedback loop drives endocrine therapy-resistant breast cancer. Proc Natl Acad Sci U S A. 2018 08 14; 115(33):8236-8238.
Score: 0.134